Show simple item record

Authordc.contributor.authorLecaros, C.
Authordc.contributor.authorDunstan Escudero, Jocelyn Mariel
Authordc.contributor.authorVillena, F.
Authordc.contributor.authorAshcroft, D. M.
Authordc.contributor.authorParisi, R.
Authordc.contributor.authorGriffiths, C. E. M.
Authordc.contributor.authorHärtel, S.
Authordc.contributor.authorMaul, J. T.
Authordc.contributor.authorCruz, C. de la
Admission datedc.date.accessioned2021-12-16T17:52:14Z
Available datedc.date.available2021-12-16T17:52:14Z
Publication datedc.date.issued2021
Cita de ítemdc.identifier.citationClinical and Experimental Dermatology (2021) 46, pp 1262–1269es_ES
Identifierdc.identifier.other10.1111/ced.14713
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/183260
Abstractdc.description.abstractBackground. Psoriasis is a serious and chronic noncommunicable disease. However, the fundamental measure of disease occurrence, the incidence, has been scarcely reported globally. There are no previous studies of psoriasis incidence in Latin America. Aim. To estimate the incidence rates of psoriasis in Chile during 2016 and 2017 using an administrative database, the Waiting List Repository. Methods. We examined referrals of psoriasis at onset, made by physicians to dermatologists, evaluated the agreement of diagnosis, and estimated the incidence of the disease considering the eligible population at risk. Results. In most cases, the referrals corresponded to incident cases of psoriasis (73.3%; 95% CI: 66.6–79.2). The national incidence rates of psoriasis were 22.1 (95% CI: 21.1–23.1) and 22.7 (95% CI: 21.8–23.6) per 100 000 person-years in 2016 and 2017, respectively. The most common type of psoriasis was the late-onset type. We observed a high variation in the figures throughout the country, with a range from 0.75 (95% CI: 0.3–1.5) per 100 000 person-years in the Metropolitan region to 164.9 (95% CI: 138.6–195.1) per 100 000 person-years in the Aysen region. Conclusion. We describe for the first time the incidence of psoriasis in a Latin American country. Our findings could potentially guide collaborations to improve our global understanding of psoriasis in Latin America.es_ES
Patrocinadordc.description.sponsorshipComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) CONICYT PIA/BASAL AFB170001 Deutscher Akademischer Austausch Dienst (DAAD) European Commission 57168868 57220037 Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) CONICYT FONDECYT 1181823 National Institute for Health Research (NIHR) Origen de datos de financiación:Medline Aparece en contenido como:National Institute for Health Research (NIHR) Manchester Biomedical Research Centre FONDEF ANID COVID0733 CORFO 16CTTS-66390 ICM P09-015-Fes_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherWileyes_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
Sourcedc.sourceClinical and Experimental Dermatologyes_ES
Keywordsdc.subjectPrevalencees_ES
Keywordsdc.subjectTrendses_ES
Títulodc.titleThe incidence of psoriasis in Chile: an analysis of the National waiting list Repositoryes_ES
Document typedc.typeArtículo de revistaes_ES
dc.description.versiondc.description.versionVersión publicada - versión final del editores_ES
dcterms.accessRightsdcterms.accessRightsAcceso abiertoes_ES
Catalogueruchile.catalogadorcfres_ES
Indexationuchile.indexArtículo de publícación WoSes_ES
Indexationuchile.indexArtículo de publicación SCOPUSes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States